The Role of the Consultant Pharmacist in Pharmacovigilance: Enhancing Medication Safety and Public Health
Article Sidebar
Page Numbers:
15-23
Digital Object Identifier:
10.58578/ajcmpr.v3i1.8013
Viewed: 161 times
Downloaded: 125 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:
Ode Edward Innocent1 
Copyright :
Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Pharmacovigilance is essential for ensuring the continued safety and efficacy of pharmaceuticals, particularly in post-marketing settings where adverse drug reactions (ADRs) may emerge beyond controlled clinical trial conditions. In Nigeria, Consultant Pharmacists have become central actors in advancing pharmacovigilance practice. Equipped with advanced qualifications such as the MPharm (Clinical) and FWAPCP, and formally recognized by the National Agency for Food and Drug Administration and Control (NAFDAC) and the Federal Ministry of Health (FMoH), they lead institutional and national efforts in ADR detection, post-marketing surveillance, signal detection, pharmacoepidemiology, risk management, and patient safety. This article examines the evolving role of Consultant Pharmacists as pharmacovigilance leaders, educators, policy influencers, and clinical collaborators. Despite their expanding influence, significant challenges persist, including underreporting, limited digital infrastructure, and gaps in pharmacovigilance education among community members. Strengthening the integration of Consultant Pharmacists into healthcare governance structures is vital for building a resilient, safety-focused pharmaceutical care system. Their contributions are pivotal not only for ensuring regulatory compliance but also for safeguarding public health and enhancing the quality of pharmaceutical care delivery.
Citation Metrics:
Article Details
References
Abubakar, I., Dalglish, S. L., Angell, B., Sanuade, O., Abimbola, S., Adamu, A. L., Adetifa, I. M. O., Colbourn, T., Ogunlesi, A. O., Onwujekwe, O., Owoaje, E. T., Okeke, I. N., Adeyemo, A., Aliyu, G., Aliyu, M. H., Aliyu, S. H., Ameh, E. A., Archibong, B., Ezeh, A., … Zanna, F. H. (2022). The Lancet Nigeria Commission: investing in health and the future of the nation. The Lancet, 399(10330), 1155–1200. https://doi.org/10.1016/S0140-6736(21)02488-0
Adenuga, B. A., Kibuule, D., Bamitale, K. D. S., & Rennie, T. W. (2020). Effective integration of pharmacovigilance systems at public health facilities in resource-limited settings: A qualitative study. Research in Social and Administrative Pharmacy, 16(8), 1111–1116. https://doi.org/10.1016/J.SAPHARM.2019.11.010
Bérard, A. (2021). Pharmacoepidemiology Research-Real-World Evidence for Decision Making. Frontiers in Pharmacology, 12, 723427. https://doi.org/10.3389/FPHAR.2021.723427
Celi, L. A., Moseley, E., Moses, C., Ryan, P., Somai, M., Stone, D., & Tang, K. O. (2014). From Pharmacovigilance to Clinical Care Optimization. Big Data, 2(3), 134. https://doi.org/10.1089/BIG.2014.0008
Cousins, D. D., & Heath, W. M. (2008). The national coordinating council for medication error reporting and prevention: Promoting patient safety and quality through innovation and leadership. Joint Commission Journal on Quality and Patient Safety, 34(12), 700–702. https://doi.org/10.1016/S1553-7250(08)34091-4
Croke, K., &Ogbuoji, O. (2024). Health reform in Nigeria: the politics of primary health care and universal health coverage. Health Policy and Planning, 39(1), 22–31. https://doi.org/10.1093/HEAPOL/CZAD107
Fred Ezeh. (2021, May). Pharmacist consultancy services kicks off in Nigeria. https://thesun.ng/pharmacist-consultancy-services-kicks-off-in-nigeria/#google_vignette
Jeetu, G., & Anusha, G. (2010). Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring. Journal of Young Pharmacists, 2(3), 315–320. https://doi.org/10.4103/0975-1483.66802
Kumar, A. (2017). Pharmacovigilance: Importance, concepts, and processes. American Journal of Health-System Pharmacy, 74(8), 606–612. https://doi.org/10.2146/AJHP151031
Menang, O., Kuemmerle, A., Maigetter, K., & Burri, C. (2023). Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: A scoping review. BMJ Open, 13(9). https://doi.org/10.1136/BMJOPEN-2022-071079
MG, R., Kumar V, P., & S, Y. (2016). Roles of Pharmacist in Pharmacovigilance: A Need of the Hour. Journal of Pharmacovigilance, 04(06). https://doi.org/10.4172/2329-6887.1000221
Moyo, E., Moyo, P., Mangoya, D., Imran, M., &Dzinamarira, T. (2023). Adverse drug reaction reporting by healthcare providers in sub-Saharan Africa: A scoping review of the challenges faced and the strategies to address the challenges. International Journal of Africa Nursing Sciences, 19. https://doi.org/10.1016/j.ijans.2023.100639
Mutair, A. Al, Alhumaid, S., Shamsan, A., Zaidi, A. R. Z., Mohaini, M. Al, Al Mutairi, A., Rabaan, A. A., Awad, M., & Al-Omari, A. (2021). The Effective Strategies to Avoid Medication Errors and Improving Reporting Systems. Medicines, 8(9), 46. https://doi.org/10.3390/MEDICINES8090046
NAFDAC. (2024a, January). Handling Adverse Drug Reactions (ADRs) - NAFDAC. https://nafdac.gov.ng/our-services/pharmacovigilance-post-market-surveillance/report-adverse-drug-reaction/
NAFDAC. (2024b, January 30). Pharmacovigilance & Post-Market Surveillance - NAFDAC. https://nafdac.gov.ng/our-services/pharmacovigilance-post-market-surveillance/
Tech Diary. (2025). Pharmacovigilance Consultants and Their Role in Post-Market Surveillance of Pharmaceuticals - Teach Diary. https://teachdiary.com/pharmacovigilance-consultants-and-their-role-in-post-market-surveillance-of-pharmaceuticals/
WHO. (2025, June 12). Regulation and Prequalification. https://www.who.int/teams/regulation-prequalification/regulation-and-safety/pharmacovigilance/pvg-archive